Although heart disease is the leading cause of death in the United States, a significant portion of people who experience ...

Cleerly has claimed an additional $106 million in funding to boost the reach of its artificial intelligence programs for ...

The company has generated evidence that shows its system is better than experts at assessing vessel narrowing, plaque volume ...

The companies plan to integrate and pilot their combined technologies to gain insight into improving cardiovascular care.

Cleerly aims to use its AI-driven plaque detection technology to develop a new standard of care for heart disease.

The investment is the second in as many weeks for Morgan Health, which co-led $80 million round in autism-focused startup, ...